MBL Life Sciences

  • HLA-A*11:01 Control Tetramer-ATAAAAAAK-APC

    MBL Life Sciences

    HLA-A*11:01 Control Tetramer-ATAAAAAAK-APC

    Catalog No.(s): MBL-TS-M152-2

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,575.00
    Choose Options
  • HLA-A*11:01 Control Tetramer-ATAAAAAAK-PE

    MBL Life Sciences

    HLA-A*11:01 Control Tetramer-ATAAAAAAK-PE

    Catalog No.(s): MBL-TS-M152-1

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,470.00
    Choose Options
  • HLA-A*02:01 Control Tetramer-ALAAAAAAV-FITC

    MBL Life Sciences

    HLA-A*02:01 Control Tetramer-ALAAAAAAV-FITC

    Catalog No.(s): MBL-TS-M151-3

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,470.00
    Choose Options
  • HLA-C*03:03 EBV EBNA1 Tetramer-FVYGGSKTSL-APC

    MBL Life Sciences

    HLA-C*03:03 EBV EBNA1 Tetramer-FVYGGSKTSL-APC

    Catalog No.(s): MBL-TS-M150-2

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,575.00
    Choose Options
  • HLA-C*03:03 EBV EBNA1 Tetramer-FVYGGSKTSL-PE

    MBL Life Sciences

    HLA-C*03:03 EBV EBNA1 Tetramer-FVYGGSKTSL-PE

    Catalog No.(s): MBL-TS-M150-1

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,470.00
    Choose Options
  • HLA-A*24:02 Influenza PB2549-557 Tetramer-TYQWIIRNW-APC

    MBL Life Sciences

    HLA-A*24:02 Influenza PB2549-557 Tetramer-TYQWIIRNW-APC

    Catalog No.(s): MBL-TS-M149-2

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,575.00
    Choose Options
  • HLA-A*24:02 Influenza PB2549-557 Tetramer-TYQWIIRNW-PE

    MBL Life Sciences

    HLA-A*24:02 Influenza PB2549-557 Tetramer-TYQWIIRNW-PE

    Catalog No.(s): MBL-TS-M149-1

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,470.00
    Choose Options
  • HLA-A*24:02 Influenza PB1498-505 Tetramer-RYGFVANF-APC

    MBL Life Sciences

    HLA-A*24:02 Influenza PB1498-505 Tetramer-RYGFVANF-APC

    Catalog No.(s): MBL-TS-M148-2

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,575.00
    Choose Options
  • HLA-A*24:02 Influenza PB1498-505 Tetramer-RYGFVANF-PE

    MBL Life Sciences

    HLA-A*24:02 Influenza PB1498-505 Tetramer-RYGFVANF-PE

    Catalog No.(s): MBL-TS-M148-1

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,470.00
    Choose Options
  • HLA-A*24:02 Influenza PB1482-490 Tetramer-SYINRTGTF-APC

    MBL Life Sciences

    HLA-A*24:02 Influenza PB1482-490 Tetramer-SYINRTGTF-APC

    Catalog No.(s): MBL-TS-M147-2

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,575.00
    Choose Options
  • HLA-A*24:02 Influenza PB1482-490 Tetramer-SYINRTGTF-PE

    MBL Life Sciences

    HLA-A*24:02 Influenza PB1482-490 Tetramer-SYINRTGTF-PE

    Catalog No.(s): MBL-TS-M147-1

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,470.00
    Choose Options
  • HLA-A*24:02 Influenza PB1430-438 Tetramer-RYTKTTYWW-APC

    MBL Life Sciences

    HLA-A*24:02 Influenza PB1430-438 Tetramer-RYTKTTYWW-APC

    Catalog No.(s): MBL-TS-M146-2

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,575.00
    Choose Options
  • HLA-A*24:02 Influenza PB1430-438 Tetramer-RYTKTTYWW-PE

    MBL Life Sciences

    HLA-A*24:02 Influenza PB1430-438 Tetramer-RYTKTTYWW-PE

    Catalog No.(s): MBL-TS-M146-1

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,470.00
    Choose Options
  • HLA-A*24:02 Influenza PB1216-224 Tetramer-SYLIRALTL-APC

    MBL Life Sciences

    HLA-A*24:02 Influenza PB1216-224 Tetramer-SYLIRALTL-APC

    Catalog No.(s): MBL-TS-M145-2

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,575.00
    Choose Options
  • HLA-A*24:02 Influenza PB1216-224 Tetramer-SYLIRALTL-PE

    MBL Life Sciences

    HLA-A*24:02 Influenza PB1216-224 Tetramer-SYLIRALTL-PE

    Catalog No.(s): MBL-TS-M145-1

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,470.00
    Choose Options
  • HLA-A*24:02 Influenza PA130-138 Tetramer-YYLEKANKI-APC

    MBL Life Sciences

    HLA-A*24:02 Influenza PA130-138 Tetramer-YYLEKANKI-APC

    Catalog No.(s): MBL-TS-M144-2

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,575.00
    Choose Options
  • HLA-A*24:02 Influenza PA130-138 Tetramer-YYLEKANKI-PE

    MBL Life Sciences

    HLA-A*24:02 Influenza PA130-138 Tetramer-YYLEKANKI-PE

    Catalog No.(s): MBL-TS-M144-1

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,470.00
    Choose Options
  • HLA-A*02:01 HHV-6B U54 Tetramer-ILYGPLTRI-APC

    MBL Life Sciences

    HLA-A*02:01 HHV-6B U54 Tetramer-ILYGPLTRI-APC

    Catalog No.(s): MBL-TS-M143-2

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,575.00
    Choose Options
  • HLA-A*02:01 HHV-6B U54 Tetramer-ILYGPLTRI-PE

    MBL Life Sciences

    HLA-A*02:01 HHV-6B U54 Tetramer-ILYGPLTRI-PE

    Catalog No.(s): MBL-TS-M143-1

    The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended...

    $1,470.00
    Choose Options